Winmill & Co’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2013
Q4
– Sell
-55,000
Closed -$2.54M – 156
2013
Q3
$2.54M Hold
55,000
– – 1.63% 9
2013
Q2
$2.46M Hold
55,000
– – 1.64% 8

Other funds holding BMY

Winmill & Co's BMY Position: Q4 2013 in Review

Winmill & Co sold out of Bristol-Myers Squibb (BMY) in Q4 2013, closing a stake of 55,000 shares — an estimated $2.54M sold.

Winmill & Co first reported a position in BMY in Q2 2013 and held it in 2 quarters. The position peaked at $2.54M in Q3 2013. 1,312 funds tracked by Wall St. Rank hold BMY as of Q4 2013.

  • Winmill & Co reported no remaining Bristol-Myers Squibb position as of Q4 2013 after selling out during the quarter.
  • Winmill & Co sold 55,000 Bristol-Myers Squibb shares in Q4 2013, an estimated $2.54M.
  • Winmill & Co first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 2 quarters.
  • Winmill & Co's Bristol-Myers Squibb position peaked at $2.54M in Q3 2013.
  • 1,312 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2013.

Based on Winmill & Co's 13F filing for Q4 2013, filed 13 Feb 2014.